Oncology & Cancer

Germany's BioNTech plans UK trial of mRNA cancer therapy

German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.

Medical research

Stem cell studies tune into hearing regeneration

A deafened adult cannot recover the ability to hear, because the sensory hearing cells of the inner ear don't regenerate after damage. In two new studies, published in the Proceedings of the National Academy of the Sciences ...

page 6 from 40